Three medications – Wegovy, Ozempic (both semaglutide), and Mounjaro (tirzepatide) – will be provided free of charge to participants in a new public obesity treatment initiative, to be launched under Greece’s “Prolamvano” preventive health program.
Three medications – Wegovy, Ozempic (both semaglutide), and Mounjaro (tirzepatide) – will be provided free of charge to participants in a new public obesity treatment initiative, to be launched under Greece’s “Prolamvano” preventive health program.